HPLC and flow cytometry combined approach for HbF analysis in fetomaternal haemorrhage evaluation.

Fetomaternal haemorrhage evaluation Flow cytometry Haemoglobin-F High performance liquid chromatography Kleihauer-Betke test

Journal

Practical laboratory medicine
ISSN: 2352-5517
Titre abrégé: Pract Lab Med
Pays: Netherlands
ID NLM: 101690848

Informations de publication

Date de publication:
May 2024
Historique:
received: 19 01 2024
revised: 14 05 2024
accepted: 15 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 30 5 2024
Statut: epublish

Résumé

Recently, a flow cytometric (FC) based test has been developed for detection of circulating fetal cells to replace the less accurate and reproducible Kleihauer-Betke test.FC test is easier to perform, it can distinguish the origin of fetal cells, but it is expensive and available in highly specialized laboratories. We evaluated the introduction of high-performance liquid chromatography (HPLC) approach as initial screening to identify patients who need an additional FC test to better discriminate the nature of haemoglobin-F (HbF) positive cells. Blood samples from 130 pregnant women suspected to have fetomaternal haemorrhage were analysed with HPLC and FC methods. The cut-off for HbF HPLC concentration was calculated. Statistical analyses for the evaluation of HPLC as a screening method were performed. The positivity cut-off of HbF to be used as decision-making value to continue the investigation was calculated. An excellent agreement (R This study provides a new FMH investigation approach that possibly leads to a reduction in times and costs of the analysis.

Identifiants

pubmed: 38812906
doi: 10.1016/j.plabm.2024.e00401
pii: S2352-5517(24)00047-7
pmc: PMC11133975
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e00401

Informations de copyright

© 2024 Published by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Benedetta Peruzzi (B)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Serena Guerrieri (S)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Tiziana Biagioli (T)

General Laboratory, AOU Careggi, Florence, Italy.

Luisa Lanzilao (L)

General Laboratory, AOU Careggi, Florence, Italy.

Sara Pratesi (S)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Sara Bencini (S)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Marinella Statello (M)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Alessia Carraresi (A)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Stefania Stefanelli (S)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Martina Tonelli (M)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Marco Brogi (M)

General Laboratory, AOU Careggi, Florence, Italy.

Manuela Capone (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Alessio Mazzoni (A)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Anna Maria Grazia Gelli (AMG)

General Laboratory San Giuseppe Hospital, Empoli, Florence, Italy.

Alessandra Fanelli (A)

General Laboratory, AOU Careggi, Florence, Italy.

Roberto Caporale (R)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.

Francesco Annunziato (F)

Flow Cytometry Diagnostic Centre and Immunotherapy (CDCI), AOU Careggi, Largo Brambilla, 3, 50134, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Classifications MeSH